[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Claire  Mazumdar Clemon M.B.A., Ph.D.", "age": 35, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 829800, "exercisedValue": 0, "unexercisedValue": 5023506}, {"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 47, "title": "President, COO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 825750, "exercisedValue": 0, "unexercisedValue": 2526259}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 915375, "exercisedValue": 0, "unexercisedValue": 1986752}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 51, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pauline  Dufresne", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 14.26, "open": 14.26, "dayLow": 14.21, "dayHigh": 15.1, "regularMarketPreviousClose": 14.26, "regularMarketOpen": 14.26, "regularMarketDayLow": 14.21, "regularMarketDayHigh": 15.1, "payoutRatio": 0.0, "trailingPE": 2.7472117, "forwardPE": -9.180124, "volume": 432548, "regularMarketVolume": 432548, "averageVolume": 584544, "averageVolume10days": 691890, "averageDailyVolume10Day": 691890, "bid": 14.7, "ask": 14.91, "bidSize": 7, "askSize": 7, "marketCap": 809677248, "fiftyTwoWeekLow": 7.8, "fiftyTwoWeekHigh": 22.675, "allTimeHigh": 28.09, "allTimeLow": 7.8, "fiftyDayAverage": 14.8504, "twoHundredDayAverage": 12.7121, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 521485216, "profitMargins": 0.0, "floatShares": 24281552, "sharesOutstanding": 54781950, "sharesShort": 6457982, "sharesShortPriorMonth": 5457251, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.1183, "heldPercentInsiders": 0.12142, "heldPercentInstitutions": 0.94165003, "shortRatio": 8.58, "shortPercentOfFloat": 0.1849, "impliedSharesOutstanding": 54781950, "bookValue": 7.375, "priceToBook": 2.0040677, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -121521000, "trailingEps": 5.38, "forwardEps": -1.61, "enterpriseToEbitda": -3.697, "52WeekChange": -0.2570982, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 14.78, "targetHighPrice": 48.0, "targetLowPrice": 8.0, "targetMeanPrice": 32.14286, "targetMedianPrice": 36.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 290167008, "totalCashPerShare": 5.297, "ebitda": -141042000, "totalDebt": 1975000, "quickRatio": 13.799, "currentRatio": 14.142, "debtToEquity": 0.49, "returnOnAssets": -0.18591, "returnOnEquity": -0.26639998, "freeCashflow": -75155376, "operatingCashflow": -112980000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.0, "postMarketPrice": 14.78, "postMarketChange": 0.0, "regularMarketChange": 0.52, "regularMarketDayRange": "14.21 - 15.1", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 584544, "fiftyTwoWeekLowChange": 6.9799995, "fiftyTwoWeekLowChangePercent": 0.8948717, "fiftyTwoWeekRange": "7.8 - 22.675", "fiftyTwoWeekHighChange": -7.8949995, "fiftyTwoWeekHighChangePercent": -0.3481808, "fiftyTwoWeekChangePercent": -25.70982, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 5.38, "epsForward": -1.61, "epsCurrentYear": -2.4975, "priceEpsCurrentYear": -5.9179177, "regularMarketChangePercent": 3.64656, "regularMarketPrice": 14.78, "corporateActions": [], "postMarketTime": 1763155201, "regularMarketTime": 1763154002, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.07040024, "fiftyDayAverageChangePercent": -0.004740629, "twoHundredDayAverageChange": 2.0678997, "twoHundredDayAverageChangePercent": 0.16267176, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]